Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
Clinical trial NCT01122251 · COMPLETED
Trial details
- NCT number
- NCT01122251
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2010-05-01
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.